Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Viscomi, CF"'
Autor:
Viscomi, CF
Loss of SURF1, a Complex IV assembly protein, was reported to increase lifespan in mice despite dramatically lower cytochrome oxidase (COX) activity. Consistent with this, our previous studies found advantageous changes in metabolism (reduced adiposi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0eaf359d41394226e09aa55a6bf8b00
Autor:
Viscomi, CF, Qualdalti, Corinne, Brunetti, Dario, Cerutti, Raffaele, Johnson, Mark, Bottani, Emanuela, Fernandez-Vizarra, Erika, Robinson, Alan, Zeviani, Massimo
Leigh syndrome (LS) associated with cytochrome c oxidase (COX) deficiency is an early onset, fatal mitochondrial encephalopathy, leading to multiple neurological failure and eventually death, usually in the first decade of life. Mutations in SURF1, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479774617ed140fe185032662618c21b
https://www.repository.cam.ac.uk/handle/1810/277288
https://www.repository.cam.ac.uk/handle/1810/277288
Autor:
Viscomi, CF, Zeviani, M
Leigh syndrome (LS) is the most common infantile mitochondrial encephalopathy. No treatment is currently available for this condition. Mice lacking $\textit{Ndufs4}$, encoding NADH: ubiquinone oxidoreductase iron-sulfur protein 4 recapitulates the ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e3241f7216a4d37c74bf943174e1f8d
Autor:
Viscomi, CF, Garone, Caterina
Preclinical work aimed at developing new therapies for mitochondrial diseases has recently given new hopes and opened unexpected perspectives for the patients affected by these pathologies. In contrast, only minor progresses have been achieved so far
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dadcc42a95b0ef16b66c47268efc6401